+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Astigmatism Drug"

Astigmatism - Pipeline Insight, 2024 - Product Thumbnail Image

Astigmatism - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Astigmatism - Epidemiology Forecast - 2032 - Product Thumbnail Image

Astigmatism - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
  • 3 Results (Page 1 of 1)
Loading Indicator

The Astigmatism Drug market is a subset of the Optical Disorders Drugs market, which includes drugs used to treat vision-related disorders. Astigmatism is a common eye condition that causes blurred vision due to an irregularly shaped cornea. Astigmatism Drugs are used to correct the shape of the cornea and improve vision. These drugs are typically administered topically, either as eye drops or ointments. Astigmatism Drugs are used to treat a variety of vision-related disorders, including myopia, hyperopia, and presbyopia. These drugs are also used to treat astigmatism-related conditions such as amblyopia and strabismus. In addition, Astigmatism Drugs are used to treat eye infections and inflammation. Some companies in the Astigmatism Drug market include Allergan, Bausch + Lomb, Novartis, Pfizer, and Santen Pharmaceuticals. Show Less Read more